CD8A and stomatitis: AZT has been shown to reduce viral load, with improvements in immunologic status (including CD4+/CD8+ ratios), quality of life, life‐expectancy and clinical status, particularly in neurologic presentations of FIV or FIV‐associated stomatitis.104, 105, 106, 107